# OnCo record inovio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/inovio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "inovio" ;
  schema:name "Inovio Pharmaceuticals"@en ;
  schema:alternateName "Inovio"@en, "INOVIO Pharmaceuticals, Inc."@en ;
  schema:description "Inovio is a US company developing DNA medicines delivered by electroporation, whose lead cancer-related programme VGX-3100 treats the HPV-caused precancerous cervical lesions that lead to cervical cancer."@en ;
  schema:url <https://onco.cc/companies/inovio/>, <https://www.inovio.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Inovio_Pharmaceuticals> ;
  owl:sameAs <http://www.wikidata.org/entity/Q30283331> ;
  schema:citation <https://www.inovio.com>, <https://clinicaltrials.gov/search?lead=Inovio%20Pharmaceuticals>, <https://en.wikipedia.org/wiki/Inovio_Pharmaceuticals> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/glioblastoma/> ;
  onco:sections <https://onco.cc/fronts/prevention/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:drugs <https://onco.cc/drugs/ino-5401/> ;
  onco:trials <https://onco.cc/trials/nct03491683/> .